STELLA YAGHOUBZADEH: Open Payments
NPI 1306314653 · CULVER CITY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,669 in 15 payments from 10 companies in 2025. Trend: 2023 $124 · 2024 $966 · 2025 $1,669
Food & beverage: $1,669
| Company | Payments | Amount |
|---|---|---|
| Genentech, Inc. | 3 | $378 |
| SK Life Science, Inc. | 2 | $233 |
| CATALYST PHARMACEUTICALS, INC. | 1 | $167 |
| Amneal Pharmaceuticals LLC | 1 | $164 |
| GENZYME CORPORATION | 1 | $148 |
| ARGENX US, INC. | 1 | $145 |
| Novartis Pharmaceuticals Corporation | 1 | $125 |
| Biogen, Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $118 |
| Eisai Inc. | 3 | $65 |
Products named: Ocrevus, FYCOMPA, CREXONT, VYVGART HYTRULO, KESIMPTA, TYSABRI, REXULTI, Ocrevus Zunovo.
Industry payments across CA — which companies pay providers there.
